Open/Close Menu Unitat D'Investigació Clínica

Dr. Balaguer of the General University Hospital of Catalonia talks about Alzheimer’s disease  

Related Stories

Parkinson REASON UDIC

The General Hospital of Catalonia, the first hospital in Spain to be activated for the phase I trial at Parkinson’s REASON

17 de January de 2020

The main purpose of this study is to evaluate the safety and tolerability of single…

Compartir:
Posted in: News

Our clinical trials unit remains in prominent position

9 de January de 2020

We have reached the first position, in December 2019, in the international inclusion of patients…

Compartir:
Posted in: Alzeimer, News, Parkinson

Biogen will request the approval to FDA of a new drug in early Alzheimer’s disease.

12 de November de 2019

  On October 22, 2019, Biogen announced the positive result of its EMERGE clinical trial…

Compartir:
Posted in: Alzeimer, News

Dental germ in patients with moderate Alzheimer’s disease

29 de October de 2019

We are developping a clinical trial  that evaluates the efficacy and safety of an oral…

Compartir:
Posted in: News

Our Parkinson’s and Alzheimer’s research unit

28 de October de 2019

– Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and…

Compartir:
Posted in: News

© 2017 - Unitat d'investigació Clinica S.L. by Tito surribas

↑

No dude en llamarnos        1-+34 935 656 000